Personalized Music Therapy Reduces Tinnitus Severity

A novel sound therapy that embeds specific therapeutic tones within music led to greater reductions in tinnitus-related distress than a control treatment over three months. The pilot study from the Otolaryngology Department at Hospital Clínico Universidad de Chile suggests this modified Music-Integrated Desynchronization Sound Therapy (mMIDST) could offer a more practical and tolerable approach to managing chronic tinnitus.

The Rationale: Targeting Maladaptive Brain Networks

Tinnitus is increasingly understood as a disorder of the brain, not just the ear. Chronic phantom ringing or buzzing is associated with maladaptive plasticity and abnormal, synchronized neural activity across auditory and non-auditory brain networks. Acoustic desynchronization therapies aim to “unlearn” these pathological patterns by delivering carefully timed sounds to disrupt the synchronization. However, a major barrier has been the practical application: many protocols require prolonged daily listening to simple, often unengaging tones, which can lead to poor patient adherence.

To solve this, the Chilean research team developed a modified protocol. Their mMIDST method embeds the precise, desynchronizing tonal stimulation within the complex acoustic structure of music. The goal was to maintain the proposed neurological benefits while drastically improving tolerability and engagement, making the therapy more viable for regular use.

Study Design: A Controlled Comparison Against an Active Placebo

Between July 2024 and July 2025, the researchers conducted a prospective, randomized, controlled, single-blind pilot trial. They enrolled adults aged 18–75 with chronic, non-pulsatile tinnitus. Participants were randomly assigned to one of two groups.

The experimental group received the modified Music-Integrated Desynchronization Sound Therapy (mMIDST). The control group received an active control intervention: low-frequency stimulation (LFS) embedded within the exact same music tracks. This design was critical. It ensured that any observed differences were likely due to the specific desynchronizing properties of the mMIDST tones, not just the act of listening to music itself. All participants listened to their personalized sound files for one hour daily, five days per week.

Tinnitus severity was the primary outcome, measured using the validated Tinnitus Handicap Inventory (THI). Audiometric evaluations and THI scores were collected at baseline and then after one, two, and three months of treatment. The researchers used the Mann–Whitney U test to analyze between-group differences.

Findings: A Time-Dependent Advantage for the Music-Integrated Therapy

Twenty-five participants completed the full study protocol—15 in the mMIDST group and 10 in the LFS control group. At the start, both groups had comparable hearing thresholds and levels of tinnitus distress.

While both groups showed some improvement over time, the mMIDST group pulled ahead significantly. The data revealed that participants using the music-integrated desynchronization therapy achieved statistically greater reductions in their THI scores than the control group at the two-month and three-month assessments. The effect became clearer with longer treatment duration.

This finding, detailed in their publication in Brain Sciences, suggests that the therapeutic component of mMIDST provides a benefit beyond general music listening. The authors, Henriquez, Delano, and Herrada, conclude that “mMIDST was associated with time-dependent improvements in tinnitus-related distress compared with an active control condition.”

Practical Implications and Future Directions

This pilot study offers a practical path forward for desynchronization-based tinnitus therapies. By successfully integrating treatment tones into music, the protocol addresses a key weakness of prior methods: patient compliance. A one-hour daily session of pleasant music is far more sustainable for most people than listening to abstract tones.

The results also reinforce the neurological model of tinnitus. The superior performance of mMIDST over the music-only control indicates that disrupting aberrant neural synchrony is a viable treatment target. This aligns with other research exploring how tinnitus phenotypes are linked to distinct patterns of brain connectivity and activity.

As a pilot trial, the study has limitations, including its relatively small sample size and single-blind design. Larger, double-blind randomized controlled trials are needed to confirm these promising results. Furthermore, it remains to be seen how this therapy interacts with individual patient factors. For instance, a person’s age and specific auditory profile might influence treatment response, a consideration for future personalization of the therapy.

For patients and clinicians, this research points to an emerging class of sound therapies that are both theoretically grounded and user-friendly. It represents a step toward moving effective neuromodulatory treatments from specialized clinics into manageable home-based routines, potentially offering relief for the persistent distress of chronic tinnitus.

Source: Henriquez PI, Delano PH, Herrada J. Modified Music-Integrated Desynchronization Sound Therapy for Chronic Tinnitus: A Pilot Study. Brain Sci. 2024;16(6):644. doi:10.3390/brainsci16060644.